Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference
Seres Therapeutics, a leading live biotherapeutics company, has announced its participation in the Cantor Global Healthcare Conference. Eric Shaff, the company's President and CEO, will deliver a presentation on September 18, 2024, at 3:05 p.m. ET.
Investors and interested parties can access a video webcast of the presentation through the "Events and Presentations" tab on the "Investors and News" section of Seres' website. The replay will be available approximately one hour after the event and will remain accessible for 21 days.
This participation in a major healthcare conference demonstrates Seres Therapeutics' commitment to engaging with the investment community and sharing updates on their progress in the live biotherapeutics field.
Seres Therapeutics, un'azienda leader nel campo delle bioterapie viventi, ha annunciato la sua partecipazione alla Cantor Global Healthcare Conference. Eric Shaff, Presidente e CEO dell'azienda, presenterà il suo intervento il 18 settembre 2024, alle 15:05 ET.
Investitori e parti interessate possono accedere a un webcast video della presentazione tramite la scheda "Eventi e Presentazioni" nella sezione "Investitori e Notizie" del sito web di Seres. La registrazione sarà disponibile circa un'ora dopo l'evento e rimarrà accessibile per 21 giorni.
Questa partecipazione a una importante conferenza nel settore sanitario dimostra l'impegno di Seres Therapeutics nel dialogare con la comunità d'investimento e nel condividere aggiornamenti sui propri progressi nel campo delle bioterapie viventi.
Seres Therapeutics, una empresa líder en bioterapias vivas, ha anunciado su participación en la Cantor Global Healthcare Conference. Eric Shaff, Presidente y CEO de la empresa, realizará una presentación el 18 de septiembre de 2024, a las 3:05 p.m. ET.
Los inversores y partes interesadas pueden acceder a un webcast en video de la presentación a través de la pestaña "Eventos y Presentaciones" en la sección "Inversores y Noticias" del sitioweb de Seres. La grabación estará disponible aproximadamente una hora después del evento y permanecerá accesible durante 21 días.
Esta participación en una importante conferencia de atención médica demuestra el compromiso de Seres Therapeutics de interactuar con la comunidad inversora y compartir actualizaciones sobre su progreso en el campo de las bioterapias vivas.
세레스 테라퓨틱스(Seres Therapeutics), 생물학적 치료제 전문 기업,가 칸토 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 에릭 샤프 CEO가 2024년 9월 18일 오후 3시 5분 ET에 발표를 할 예정입니다.
투자자 및 관심 있는 분들은 세레스 웹사이트의 "투자자 및 뉴스" 섹션에서 "이벤트 및 발표" 탭을 통해 발표의 비디오 웹캐스트를 접근할 수 있습니다. 이벤트가 끝난 후 약 1시간 후에 재생이 가능하며, 21일 동안 접근할 수 있습니다.
이번 주요 헬스케어 컨퍼런스 참여는 세레스 테라퓨틱스의 투자 커뮤니티와의 소통과 생물학적 치료제 분야의 진행 상황을 공유하려는 노력의 일환입니다.
Seres Therapeutics, une entreprise leader dans le domaine des biothérapies vivantes, a annoncé sa participation à la Cantor Global Healthcare Conference. Eric Shaff, Président et CEO de l'entreprise, fera une présentation le 18 septembre 2024, à 15h05 ET.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire vidéo de la présentation via l'onglet "Événements et Présentations" dans la section "Investisseurs et Nouvelles" du site web de Seres. La rediffusion sera disponible environ une heure après l'événement et restera accessible pendant 21 jours.
Cette participation à une conférence majeure sur la santé démontre l'engagement de Seres Therapeutics à interagir avec la communauté des investisseurs et à partager des mises à jour sur leurs progrès dans le domaine des biothérapies vivantes.
Seres Therapeutics, ein führendes Unternehmen im Bereich der lebenden Biotherapeutika, hat seine Teilnahme an der Cantor Global Healthcare Conference angekündigt. Eric Shaff, Präsident und CEO des Unternehmens, wird am 18. September 2024 um 15:05 Uhr ET eine Präsentation halten.
Investoren und Interessierte können über den Tab "Veranstaltungen und Präsentationen" im Bereich "Investoren und Nachrichten" der Website von Seres auf einen Video-Webcast der Präsentation zugreifen. Die Aufzeichnung wird etwa eine Stunde nach der Veranstaltung verfügbar sein und für 21 Tage abrufbar bleiben.
Die Teilnahme an einer wichtigen Gesundheitskonferenz zeigt das Engagement von Seres Therapeutics, mit der Investitionsgemeinschaft in Kontakt zu treten und Updates über ihre Fortschritte im Bereich der lebenden Biotherapeutika zu teilen.
- None.
- None.
CAMBRIDGE, Mass., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that the Company, will participate in the Cantor Global Healthcare Conference and Eric Shaff, President and Chief Executive Officer, will represent Seres in a presentation on September 18, 2024 at 3:05 p.m. ET.
A video webcast of the presentation will be available under the “Events and Presentations” tab on the “Investors and News” section of Seres’ website. The replay will become available approximately one hour after the event and will be archived for 21 days.
About Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics. Seres led the successful development and approval of VOWST™, the first FDA-approved orally administered microbiome therapeutic. The Company is developing SER-155, designed to prevent gastrointestinal-derived bloodstream infections, enhance epithelial barrier integrity, and induce immune tolerance responses to reduce the incidence of graft-versus-host-disease. The Company is also advancing additional cultivated oral live biotherapeutics for medically vulnerable populations, including those with chronic liver disease, cancer neutropenia, and solid organ transplants. For more information, please visit www.serestherapeutics.com.
Investor and Media Contacts:
IR@serestherapeutics.com
Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com
FAQ
When is Seres Therapeutics (MCRB) presenting at the Cantor Global Healthcare Conference?
Who will be representing Seres Therapeutics (MCRB) at the Cantor Global Healthcare Conference?
How can investors access the Seres Therapeutics (MCRB) presentation at the Cantor conference?
How long will the replay of Seres Therapeutics' (MCRB) presentation be available?
